KRYS — Krystal Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Krystal Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	438	379	532	598	828
Net Total Accounts Receivable
Net Total Receivables	—	—	42	105	127
Total Inventory
Prepaid Expenses
Total Current Assets	442	384	588	742	1,025
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	120	170	168	161	158
Long Term Investments
Other Long Term Assets
Total Assets	626	558	818	1,056	1,334
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	25.7	28.8	33.1	102	103
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	32.7	36.2	39.7	109	114
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	594	522	779	946	1,220
Total Liabilities & Shareholders' Equity	626	558	818	1,056	1,334
Total Common Shares Outstanding